In MS and SLE patients, Abzs against myelin oligodendrocyte glycoprotein (MOG) and myelin basic protein (MBP) possessing protease activity may attack proteins of the myelin–proteolipid sheath of axons. The gene discussed is MOG; the disease is systemic lupus erythematosus.